Quebec Metastatic Breast Cancer Registry 

The Registry is a database that collects information on metastatic breast cancer cases in Quebec. 

Initiated by the Scientific Committee of the McPeak-Sirois Group, and under the leadership of Dr Sarkis Meterissian, the Registry is the first in Quebec. This foremost initiative, in partnership with the Ministère de la Santé et des Services sociaux (MSSS) and the Direction nationale du Programme québécois de cancérologie du Québec.

The Registry launched in 2021 with 3 participating hospitals: McGill University Health Centre, the Centre hospitalier de l’Université de Montréal and the CHU de Québec-Université Laval. In 2023, all other hospitals that are members of the Group in Quebec will be able to contribute to the project. 

CCS is providing $2.5 million over 5 years to expand the Registry, with the goal of eventually including all types of breast cancer in Quebec.

Having access to robust, trustworthy data benefits the entire cancer ecosystem – from patients to healthcare professionals, support organizations and research centres. It will lead to a better understanding of the disease and eventually to the optimization of clinical practice. 

The Registry also fosters collaboration between researchers and gives them access to crucial patient data needed to understand how people with metastatic breast cancer are treated in Quebec and how they respond to that treatment.